ODS Goes to ASN's Nutrition 2019

The calendar includes information about these ODS funding opportunities:

ODS provides funding through competitively awarded Administrative Supplements to certain active NIH research awards to support research in which the supplemental funding would investigate the role of dietary supplements and/or their ingredients in health maintenance and disease prevention. Parent awards do not need to focus on dietary supplements; this funding opportunity announcement (FOA) may provide support to include dietary supplements within the scope of relevant research projects. Research interests of ODS are not limited to specific health conditions, organ systems, or population groups. ODS supports all types of research, including pre-clinical, clinical, behavioral, and epidemiological.

The next due date is October 15, 2019.

For additional information, contact Cindy Davis at [email protected].

The reproducibility and comparability of research on dietary supplements is enhanced by rigorous analytical characterization of key experimental materials and the publication of validated analytical methods that accurately and precisely characterized and quantify constituents in dietary supplement ingredients and products. This FOA builds on existing NIH awards to support the performance and publication of formal single-laboratory validation studies of quantitative analytical methods. The methods proposed for validation must be used to identify and quantify dietary supplement-relevant chemical constituents (i.e., active or marker chemical compounds, adulterants, contaminants) or their metabolites in experimental reagents, raw materials, and/or clinical specimens (e.g., urine or plasma samples). Methods must have been developed or utilized in fulfillment of the active parent grant's specific aims. Candidate constituents for quantitative method validation studies include (but are not limited to): phytochemicals, nutrients, and potentially deleterious substances such as pesticides and mycotoxins. Multi-laboratory validation studies will not be supported through this FOA.

The next due date is October 15, 2019.

For additional information, contact Adam Kuszak at [email protected].